PUBLISHER: IMARC | PRODUCT CODE: 1801058
PUBLISHER: IMARC | PRODUCT CODE: 1801058
The global high-performance liquid chromatography (HPLC) market size reached USD 5.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.4 Billion by 2033, exhibiting a growth rate (CAGR) of 3.9% during 2025-2033.
High-performance liquid chromatography (HPLC) refers to the chromatographic technique of separating different compounds from a mixture. The technique uses a glass reservoir to hold the solution, numerous pumps to pass the pressurized liquid solvent containing the sample mixture, a column filled with a solid adsorbent material, fluorescence, mass-spectrometric, ultraviolet (UV)-spectroscopic and electrochemical detectors and data collection systems. It is commonly used for analytical chemistry and biochemistry to identify, quantify and purify individual components. As a result, the technique finds extensive applications for trace analysis, clinical diagnosis of diseases, quality control in food products and pharmaceutical drug development.
Significant growth in the pharmaceutical industry across the globe represents one of the key factors creating a positive outlook for the market. HPLC is widely used to analyze drug samples, quality control, manufacturing complex pharmaceutical drugs and obtaining faster and accurate compound separation results. Furthermore, the increasing demand for reliable HPLC systems for the purification of monoclonal antibodies is also driving the market growth. Various advancements in the column and pump technologies and the development of miniaturized, automated and computerized HPLC devices are acting as other growth-inducing factors. These advancements have assisted in conducting high-quality analysis that provides more accurate results in lesser time and enhances the overall convenience for the user. HPLC instrument manufacturers are also developing innovative column designs that can withstand high pressure from smaller, superficially porous particles, which is acting as another major growth-inducing factor. The emerging trend of biobanking and extensive research and development (R&D) activities in the field of life sciences are some of the other factors that are anticipated to drive the market further.
The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Bio-RAD Laboratories Inc., Gilson Inc., Hitachi Ltd., Perkinelmer Inc., Phenomenex Inc. (Danaher Corporation), Shimadzu Corporation, Thermo Fisher Scientific Inc., Tosoh Corporation and Waters Corporation.